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Figure 1. Necrotizing fasciitis due to Streptococcus pneumoniae after
im injection of nonsteroidal anti-inflammatory drugs in a 68-year-old man
(left thigh with site of injection on admission). Note minimal erythema
of clearly demarcated area.
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Two cases of pneumococcal necrotizing fasciitis (NF) oc-
curred after intramuscular injections of nonsteroidal anti-
inflammatory drugs; another 5 cases reported in the litera-
ture fulfilled the criteria for NF involving Streptococcus
pneumoniae. Conditions associated with alterations of im-
mune function could be identified in 6 of the 7 cases; 2
patients died despite surgical and antimicrobial treatment.
“Necrotizing fasciitis” (NF), a term introduced by Wilson [1],
was first described as “hospital gangrene” in the American Civil
War era [2]. It is a life-threatening infection of the superficial
muscle fascia and the adjacent deep layer of the subcutaneous
tissue. Progression to septic shock can occur within hours; the
mortality rate ranges from 20% to 60% [3]. It is usually caused
by b-hemolytic streptococci or a polymicrobial infection of
both anaerobic and aerobic flora. Initially, local pain seems out
of proportion to physical findings. Later, discoloration of the
skin and development of bullae are signs of progressive necrosis
and microthrombosis, thus leading to impaired cutaneous
nerve function. These characteristics can help to differentiate
NF from cellulitis with only superficial involvement of the skin
[4]. Predisposing factors are diabetes mellitus, injection drug
abuse, age of 150 years, arterial hypertension, vascular diseases,
and obesity or malnutrition. When 3 of these factors are
present, the mortality rate seems to reach 50% [5].
NF due to Streptococcus pneumoniae is rare. We report 2
cases of pneumococcal fasciitis and review the literature. Our
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patients had been treated with im injections of nonsteroidal
anti-inflammatory drugs (NSAIDs) before infection.
Methods. Our case definition of pneumococcal NF re-
quired the presence of an infection, found by means of direct
visualization or imaging technique, that involved the superficial
muscular fascia and the surrounding deep layer of the sub-
cutaneous tissue (involvement of the muscle or the skin was
optional or secondary); pneumococci isolated from culture of
blood and/or local aspirates; and incipient or evident septic
shock (e.g., hypotonia, tachycardia, dependence on supportive
measures for circulation, multiorgan failure, or death).
We searched the literature through MEDLINE (1966–1999),
Serline (unlimited), and Science Citation Index of the Web of
Science (1983–1999) for the following terms: “pneumococcal
soft tissue infection”; “pneumococcal necrotizing fasciitis”;
“soft tissue infection/microbiology” and “etiology”; “soft tissue
infection” and “intramuscular injections”; “necrotizing fasci-
itis” and “intramuscular injections”; “intramuscular injections/
complications of”; “necrotizing fasciitis” and “nonsteroidal
anti-inflammatory drugs”; and “intramuscular injections” and
“nonsteroidal anti-inflammatory drugs.” The reference lists of
the chosen articles served as additional sources.
Case reports. The first patient was a 68-year-old man with
known arterial hypertension. Eight years prior to presentation,
an infrarenal aortic aneurysm was treated with a composite
graft. Four years prior to presentation, he had had an aortic
dissection type B, which was treated conservatively.
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Figure 2. Necrotizing fasciitis due to Streptococcus pneumoniae after
im injection of nonsteroidal anti-inflammatory drugs in a 68-year-old man
(terminal presentation of patient’s left leg, with extensive necrosis).
Figure 3. Necrotizing fasciitis due to Streptococcus pneumoniae after
im injection of nonsteroidal anti-inflammatory drugs in an 83-year-old
woman (inner right thigh after extensive surgical debridement). Note
necessity for ablation of all infected tissue unto healthy muscular layer.
Three days after onset of an upper respiratory tract infection
with cough and sore throat, he presented to his physician with
pain in his right big toe. The diagnosis of acute gout arthritis
was made, and the patient was treated with an im injection of
diclofenac, 75 mg, in his left thigh. Two days later, he com-
plained of severe pain at the injection site. He collapsed and
was admitted to our hospital the same day with refractory
hypotension.
Physical examination revealed that the patient was severely
ill, hoarse, and had a temperature of 35.7C and cold skin with
signs of impaired perfusion. His blood pressure was 70/50 mm
Hg, and his pulse was 110 beats/min. The site of the injection
was exquisitely tender, but it showed only minimal erythema
and a slight rise in temperature (figure 1). The remaining find-
ings of the physical examination were unremarkable. Labora-
tory studies showed a normal leukocyte count, with 69% band
forms, and thrombocytopenia (platelet count, 966,000 10
cells/L). There were signs of impaired coagulation, such as pro-
longed partial thromboplastin time of 42 s (normal maximum,
36 s) and an elevated fibrinogen level of 6.6 g/L (normal max-
imum, 3 g/L). The following values were also noted: creatine
kinase level, 1099 U/L (normal range, 85–350 U/L); creatinine
level, 309 mmol/L (normal range, 59–116 mmol/L); and serum
aspartate aminotransferase level, 206 U/L (normal range, 10–41
U/L). Blood gas analysis revealed severe metabolic acidosis (pH,
7.1; bicarbonate, 7.7 mmol/L [normal range, 18–29 mmol/L])
with a normal lactate level at that time. An initial normal leu-
kocyte count, normal lymphocyte count, and normal levels of
complement factors showed no evidence of a compromised
immunologic status; further tests (e.g., for HIV) were not done.
Ultrasonography of the left thigh revealed no signs of ab-
scess, blood, or air pocket formation. Nevertheless, septic
shock, probably due to NF, was strongly suspected, and the
patient underwent surgical exploration 48 h after the injection.
Intraoperative findings showed large patchy areas of necrotic
subcutaneous tissue but no abscess formation. Extensive de-
bridement was done. Antibiotic therapy with ceftriaxone, gen-
tamicin, and clindamycin was administered perioperatively.
Two days later, cultures of blood and wound aspirates yielded
penicillin-sensitive S. pneumoniae.
Despite daily extensive surgical debridements, the local and
systemic inflammatory reactions were never under control. Ne-
crosis continued to extend, involving the hip joint and lower
abdominal wall within days. Dialysis was begun on day 2. On
day 3, arterial circulation of the lower left extremity became
marginal (figure 2). On hospital day 6, the patient died of septic
shock and multiorgan failure.
The second patient was an 83-year-old woman. A mediastinal
mass had first been detected 14 years prior to presentation. A
needle aspiration was performed, but definitive diagnosis could
not be made. Because the patient remained asymptomatic, no
further diagnostic tests were done. On review, 4 years prior to
presentation, the mass had diminished in size. Laboratory tests
revealed a slight deficiency of IgA, IgG1, and IgG2. Therefore,
an adult teratoma or a thymoma was suspected.
The patient first presented to her physician with pains in the
right hip joint region. Degenerative arthritis was suspected, and
she was treated with an im injection of denoxicam in the right
thigh. Two days later, the pain had substantially increased. The
patient was now unable to walk; she seemed progressively ill,
and she was admitted the next day.
On admission, the patient was awake but disoriented. Her
temperature was 38.8C, her blood pressure was 100/60 mm
Hg, and her pulse was 100 beats/min and regular. The findings
of the physical examination were unremarkable except for a
very painful, dark-reddish defined area at the site of injection,
and both of her wrists were very tender. Laboratory studies
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Figure 4. Necrotizing fasciitis due to Streptococcus pneumoniae after
im injection of nonsteroidal anti-inflammatory drugs in an 83-year-old
woman (inner right thigh after complete wound healing by total skin
transplantation at end of hospital stay).
Table 1. Pneumococcal necrotizing fasciitis: literature review.
Author [reference] Year
Age,
years Sex Comorbidity Site
Cultures positive
for pneumococci Therapy Outcome
Present report 2001 68 M im NSAIDs Leg Local/blood Ctri, Gm, Cm, surg Died
Present report 2001 83 F im NSAIDs, thymoma Leg Local/blood Ctri, surg Survived
Lewis et al. [11] 1975 21 M Injection drug abuse Leg Local/blood Cm, Gm, surg Died
Hill and Karsh [10] 1997 30 F Systemic lupus
erythematosus
Neck Blood Pen, surg Survived
Patel et al. [8] 1994 60 F Renal failure Leg Local/blood Pen, surg Survived
Di Nubile et al. [7] 1991 18 F Systemic lupus
erythematosus
Neck Local/blood Pen, surg Survived
Choudri et al. [9] 1995 44 F Insulin-dependent
diabetes mellitus
Thigh Local Pen, surg Survived
NOTE. Cm, clindamycin; Ctri, ceftriaxone; F, female; Gm, gentamicin; M, male; Pen, penicillin; surg, surgical intervention.
revealed a normal leukocyte count, with elevated band forms,
and thrombocytopenia (platelet count, cells/L).959,000 10
Her creatinine level was 309 U/L and her creatine kinase level
was normal. The diagnosis of an incipient septic shock due to
an infection of the right thigh was made. Surgical exploration
was done immediately. The intraoperative site showed vast ne-
crosis of skin, subcutaneous tissue, and muscle fascia. On the
next day, purulent discharge was surgically removed from both
wrists. Culture of blood and local aspirates yielded S. pneu-
moniae. Therefore, the diagnosis was pneumococcal NF with
septic arthritis of both wrists. Daily surgical debridements (fig-
ure 3) and antibiotic therapy with ceftriaxone showed good
results, and the patient recovered gradually. Values for IgA,
IgG1, and IgG2 were consistently ∼20% below normal levels.
She was discharged 6 months later, after a prolonged conva-
lescence due to arthrosis and chronic diarrhea (figure 4).
Literature review and discussion. NF due to S. pneumo-
niae is rare. It is not even mentioned in systematic reviews
about soft tissue infections, such as that of Lewis [6]. Literature
review yielded 4 case reports [7–10]. One additional case report
classified as cellulitis met our criteria for NF [11] (table 1).
Pneumococci were isolated from cultures of blood and site
aspirates, in 3 cases, and cultures of either wound aspirates or
blood, in 1 case each. Besides the clinical findings, the diagnosis
of NF was confirmed by CT in 2 cases [7, 10]; by ultrasound,
in 1 case [9]; and by description of the intraoperative presen-
tation, in 2 cases [8, 11]. No trauma or skin laceration as a
concomitant factor is described, but all patients had some im-
munocompromising condition, such as injection drug abuse,
diabetes mellitus, chronic renal failure, or systemic lupus er-
ythematosus. In the patient with systemic lupus erythematosus,
concomitant hypocomplementemia and immunosuppressive
drugs were considered additive risk factors for this disease [7,
10, 12]. Two of 7 patients with pneumococcal NF died (mor-
tality rate, 29%), despite combined surgical and antimicrobial
treatment.
Our cases resemble those found in the literature. The first
patient was known to have generalized arteriosclerosis due to
longstanding arterial hypertension, which has also been listed
as a risk factor [13]. Moreover, he had had an infection of the
upper respiratory tract 3 days before injection, which is known
to favor infection with S. pneumoniae. The second patient had
a persistent immunoglobulin deficiency, probably due to the
mediastinal tumor, which made her more susceptible to pneu-
mococcal infection. Levels of complement factors were normal
at the time. The 2 cases suggest a relationship between im
injections of NSAIDs and pneumococcal NF. Conditions as-
sociated with alterations of immune function can be identified
in 6 out of 7 cases. This observation is in contrast to that of
patients presenting with group A streptococcal NF, who typi-
cally lack recognizable immune dysfunction [4].
Lethal outcomes in patients with NF who undergo therapy
with NSAIDs are reported, and the impact of these drugs on
the severity of the disease is controversial [14–16]. Their wide-
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spread use makes it difficult to define their causal contribution
to the evolution of severe infection. Nevertheless, NSAIDs en-
hance the production of TNF-a in the presence of endotoxins
[17] by impairing the normal feedback loop during the pro-
duction of TNF and other cytokines, and, therefore, acting as
an additional stimulus to the proinflammatory cascade. In ad-
dition, they are potent inhibitors of neutrophil granulocyte
chemotaxis and phagocytosis by inhibiting the lipoxygenase
pathway, which is specially true for diclofenac and indometh-
acin. In the same way, they also decrease leukotriene production
by leukocytes, which are compounds known to play a role in
the inflammatory response [18]. Finally, they confound the
progression of disease by suppressing fever and pain through
inhibition of prostaglandin synthesis, thus blurring the signs
of onset of serious infection [19].
Considering the aforementioned pathophysiological impact
of NSAIDs, treatment with NSAIDs may well have been an
accelerating factor in the evolution of NF. Intramuscular in-
jections per se can provoke severe tissue trauma, representing
a local portal of entry for infection, even when correctly ad-
ministered [20–23]. Necrosis at the infection site appears to be
independent of the drug given, and it is a strong additional
risk factor for soft tissue infection. The combination of im
injection with NSAIDs seems to multiply the risk of serious
infective complications.
Not much is known about the interaction of pneumococcal
fasciitis, im injections, and NSAIDs. In a review of the literature
(table 1), none of the other patients were described as having
received im injections or NSAIDs. An extended search for pneu-
mococcal soft tissue infections and im injections revealed 1 case
of pneumococcal cellulitis after injection of steroids [24]; 1 case
each of abscess formation after injection of NSAIDs [25], steroids,
or contraceptive drugs [26]; and 1 case of pyomyositis after
injection of a drug that most probably was an NSAID or a local
anesthetic [27]. Two additional cases of pneumococcal cellulitis
after oral application of NSAIDs were reported [28, 29].
Both of our patients were treated with im injection of NSAIDs
before admission, and both of them developed severe NF at the
injection site. The indications for the injection were pain due to
suspected gout arthritis in 1 patient and arthrosis in the other.
Considering today’s large arsenal of oral and rectal drugs with
adequate bioavailability, im applications of NSAIDs should be
used with utmost care, and, wherever possible, the means of
treatment should be changed to another application form.
In summary, we describe 2 cases of NF due to S. pneumoniae.
Our cases differ from the 5 cases we identified in the literature
by the fact that they occurred after im administration of NSAIDs.
Less severe skin infections due to S. pneumoniae that have in-
volved im injections have also been described. Most likely, host
factors, including immunodeficiency or pharmacological skewing
of host defense mechanisms, may contribute to progression of
the infection and extensive tissue damage. First-line therapy still
consists of immediate, extensive surgical debridement of necrotic
areas combined with antibiotic therapy.
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